PHASE I STUDIES OF HM781-36B, AN IRREVERSIBLE PAN-HER TYROSINE KINASE INHIBITOR (TKI) IN PATIENTS WITH ADVANCED SOLID TUMOR AND THE THERAPEUTIC POTENTIAL IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
JOURNAL OF THORACIC ONCOLOGY（2013）
关键词
HM781-36B,Pan-HER inhibitor,Phase I clinical trial,Advanced non-small cell lung cancer (NSCLC)
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要